Let’s talk about bringing your brand into this market.
Medical-device manufacturer or F&B brand, the conversation starts in the same place: the operation that will actually carry your product.
Request a callFrom licence to collections, one operation.
Entering Türkiye, the Caucasus and Central Asia takes three layers working at once: a regulatory file that holds, a physical operation that keeps stock moving, and a commercial engine that creates demand. We run all three ourselves, on the ground, and we stay accountable for the result well after the paperwork clears.
Run separately, those layers leak: the licence sits with one firm, the stock with another, the marketing with a third, and nobody answers for the outcome. We keep them under one roof, so you always know who is responsible for what.
- Regulatory affairs
- A device stays on this market only for as long as its registration and compliance hold. TİTCK and ÜTS registration, CE conformity, vigilance and adverse-event reporting all run in this layer, and we run them in-house and keep the file current.
- Operations
- We do the physical work that gets your product to the shelf and keeps it there: import, customs clearance, buffer stock and distribution. The warehouse is ours; customs and freight run through licensed service providers, with the coordination, the paperwork and the responsibility staying on our side. One counterparty answers for stock and delivery: us.
- Growth
- Availability doesn’t sell anything on its own. We build the demand: the commercial and marketing operation that turns being on the shelf into orders. And once the product sells, the receivables are ours to manage, not yours to worry about.
You can follow those three layers step by step on a single device, from the registration file through to vigilance, on the Medical page.
To be clear: Alzey works in two verticals, medical devices and F&B. For a product outside those, we’re probably not the right partner.
You choose how we work together.
Not every manufacturer wants to enter this market at the same depth. Some hand over every link from licence to collections; others want to see the regulatory route first and decide later. So we don’t force one shape onto every partnership. Below is the scope of each model; which one we start from is something we settle on the first call.
Master distribution
The licence is held in our name, and import, warehousing, field sales, receivables and collections and the patient-facing demand layer all run under that same roof. This is the fully localised operation: from the day the product enters the market to the day the invoice is collected, one operator answers for it.
Who it fits: A manufacturer entering the market properly.
Regional distribution network
We build and run the sub-distributor network across the Caucasus and Central Asia, and training and application certification stay with us. Day-to-day coordination sits on our side; direction and priorities are set together with your head office.
Who it fits: A manufacturer moving into the region.
Regulatory and market entry
We take the registration through TİTCK and complete the ÜTS record, and we read the state of the market from inside our own operation. Commercial execution sits outside this model and is taken up separately at the next stage.
Who it fits: A manufacturer testing the ground first.
What we take on, what we need from you.
A partnership works when it is clear from the start who carries what. These two lists are the division of labour we would put in front of you on the first call: the items are set out here, the detail is settled at the table.
Alzey takes on
- Registration and the regulatory file
- Preparation, the TİTCK submission, the ÜTS record and the official follow-up all run through us.
- Import, customs, warehousing and buffer stock
- Moving the product from the border to the authorised centre is our work. The warehouse is ours; customs and freight run through licensed service providers, with coordination and responsibility staying on our side.
- Field team, clinic network and physician training
- We hold the clinic relationships and run physician training and certification ourselves.
- Receivables and credit risk
- Credit risk in the channel stays on our side, and you deal with a single counterparty.
- The B2C demand layer
- We build patient-side demand through channels we own and route it to authorised centres.
We need from you
- CE or FDA technical file
- The file itself, and keeping it current as the process runs.
- Product training
- A train-the-trainer handover; repeating it in the field is on us.
- Commercial terms and price structure
- Defined before the operation starts.
- Brand kit and marketing material
- Usage rules, visual assets and the source files behind the material.
- Stock commitment and lead time
- Buffer stock can only be planned against a lead time we can predict.
- Clinical data and publication access
- Physician training in the field and the regulatory file both rest on it.
- Territory exclusivity defined in the agreement
- The geographic scope written plainly into the contract.
Two layers that set the model apart.
A three-way win (B2B2C)
The operation is built so that three parties win at once: the manufacturer sells, the clinic finds patients, and the patient gets access to treatment. We run the clinic network on the B2B side and patient demand on the B2C side, and this operation is where the two meet.
Our own systems
We run the commercial infrastructure on software we write ourselves: the clinic CRM, the WhatsApp intake line, receivables and collections analytics, clinic-level digital marketing tools and process automation. We don’t depend on an agency or on outside software.
How both layers work in the field is set out on the Medical page.
What happens after the form
Your message goes to the team that would actually run your market entry, and we come back to you with a proposed call. That first conversation has a fixed agenda: your product’s regulatory position in the target market, the commercial model we’d propose, credit and payment terms, and a rough timeline.
The shape of the partnership is fixed from the start: one agreement, one accountable counterparty — from licence to collections. No hand-offs between a consultant, an importer and an agency. And if that first call tells either side it isn’t a fit, we’ll say so plainly and leave it there.
Request a call
Leave a short message telling us which vertical you’re in and which market you have in mind; that’s enough for a first conversation.
Or write directly: info@alzeypartners.co